Listed

Bright Minds Biosciences Inc.

DRUGNasdaqCIK 1827401HealthcareFiscal year ends Sep 30

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalentsCAD 5.7m, FY2024
Shareholders' equityCAD 5.5m, FY2024
Line itemUnitperiod not labelled2018-09-30period not labelled2019-05-31period not labelled2019-09-30period not labelled2020-09-30FY20212021-09-30FY20222022-09-30FY20232023-09-30FY20242024-09-30
Cash and equivalents$m0.0Cash and equivalents, period not labelled, at 2018-09-30CAD 0. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F/A filed 2022-01-18, accession 0001062993-22-001182.Report this figurenot reported0.1Cash and equivalents, period not labelled, at 2019-09-30CAD 80.0k. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-12-29, accession 0001062993-22-024547.Report this figure0.8Cash and equivalents, period not labelled, at 2020-09-30CAD 799.9k. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2023-12-29, accession 0001062993-23-023281.Report this figure19.8Cash and equivalents, FY2021, at 2021-09-30CAD 19.8m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure11.6Cash and equivalents, FY2022, at 2022-09-30CAD 11.6m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure6.7Cash and equivalents, FY2023, at 2023-09-30CAD 6.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure5.7Cash and equivalents, FY2024, at 2024-09-30CAD 5.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure
Current assets$mnot reportednot reportednot reported0.9Current assets, period not labelled, at 2020-09-30CAD 878.2k. XBRL concept ifrs-full:CurrentAssets. 20-F/A filed 2022-01-18, accession 0001062993-22-001182.Report this figure20.0Current assets, FY2021, at 2021-09-30CAD 20.0m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-12-29, accession 0001062993-22-024547.Report this figure11.9Current assets, FY2022, at 2022-09-30CAD 11.9m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2023-12-29, accession 0001062993-23-023281.Report this figure6.8Current assets, FY2023, at 2023-09-30CAD 6.8m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure6.0Current assets, FY2024, at 2024-09-30CAD 6.0m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure
Total assets$mnot reportednot reportednot reported0.9Total assets, period not labelled, at 2020-09-30CAD 880.2k. XBRL concept ifrs-full:Assets. 20-F/A filed 2022-01-18, accession 0001062993-22-001182.Report this figure20.0Total assets, FY2021, at 2021-09-30CAD 20.0m. XBRL concept ifrs-full:Assets. 20-F filed 2022-12-29, accession 0001062993-22-024547.Report this figure12.1Total assets, FY2022, at 2022-09-30CAD 12.1m. XBRL concept ifrs-full:Assets. 20-F filed 2023-12-29, accession 0001062993-23-023281.Report this figure6.9Total assets, FY2023, at 2023-09-30CAD 6.9m. XBRL concept ifrs-full:Assets. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure6.1Total assets, FY2024, at 2024-09-30CAD 6.1m. XBRL concept ifrs-full:Assets. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure
Current liabilities$mnot reportednot reportednot reportednot reported0.6Current liabilities, FY2021, at 2021-09-30CAD 638.6k. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2022-12-29, accession 0001062993-22-024547.Report this figure1.5Current liabilities, FY2022, at 2022-09-30CAD 1.5m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2023-12-29, accession 0001062993-23-023281.Report this figure0.3Current liabilities, FY2023, at 2023-09-30CAD 280.9k. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure0.5Current liabilities, FY2024, at 2024-09-30CAD 528.7k. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure
Total liabilities$mnot reportednot reportednot reported0.2Total liabilities, period not labelled, at 2020-09-30CAD 150.9k. XBRL concept ifrs-full:Liabilities. 20-F/A filed 2022-01-18, accession 0001062993-22-001182.Report this figure0.6Total liabilities, FY2021, at 2021-09-30CAD 638.6k. XBRL concept ifrs-full:Liabilities. 20-F filed 2022-12-29, accession 0001062993-22-024547.Report this figure1.5Total liabilities, FY2022, at 2022-09-30CAD 1.5m. XBRL concept ifrs-full:Liabilities. 20-F filed 2023-12-29, accession 0001062993-23-023281.Report this figure0.3Total liabilities, FY2023, at 2023-09-30CAD 280.9k. XBRL concept ifrs-full:Liabilities. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure0.6Total liabilities, FY2024, at 2024-09-30CAD 568.3k. XBRL concept ifrs-full:Liabilities. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure
Shareholders' equity$mnot reported0.0Shareholders' equity, period not labelled, at 2019-05-31CAD 0. XBRL concept ifrs-full:Equity. 20-F/A filed 2022-01-18, accession 0001062993-22-001182.Report this figure0.0Shareholders' equity, period not labelled, at 2019-09-30CAD 45.3k. XBRL concept ifrs-full:Equity. 20-F filed 2022-12-29, accession 0001062993-22-024547.Report this figure0.7Shareholders' equity, period not labelled, at 2020-09-30CAD 729.3k. XBRL concept ifrs-full:Equity. 20-F filed 2023-12-29, accession 0001062993-23-023281.Report this figure19.4Shareholders' equity, FY2021, at 2021-09-30CAD 19.4m. XBRL concept ifrs-full:Equity. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure10.5Shareholders' equity, FY2022, at 2022-09-30CAD 10.5m. XBRL concept ifrs-full:Equity. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure6.6Shareholders' equity, FY2023, at 2023-09-30CAD 6.6m. XBRL concept ifrs-full:Equity. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure5.5Shareholders' equity, FY2024, at 2024-09-30CAD 5.5m. XBRL concept ifrs-full:Equity. 20-F filed 2024-12-31, accession 0001062993-24-021301.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.